CD8A and neoplasm: This study reveals dynamic cellular changes occurring during effective ICT and the role of a set of biomarkers connected to the cytotoxic potential of CD8+ T cells, which are instrumental in tumor immunity and could be used to assess the level of immunotherapy efficiency.